SCREEN Holdings Co., Ltd. is one of world’s largest manufacturing company with numerous market leading products. SCREEN founded its Life Science branch ‘SCREEN-Biosciences & Pharmaceuticals’ to help biomedical research community in their quest to discover more effective therapeutic options for patients. SCREEN delivers a comprehensive portfolio of imaging devices and software solutions to support preclinical drug discovery and development studies. SCREEN’s translational imaging and image analysis solutions enables the researchers to image phenotypic changes in cells grown in either 2D or 3D culture settings, within a matter of minutes which could otherwise take weeks to perform.
Building on a history that stretches back to its foundation in 1868, Dainippon Screen Mfg. Co., Ltd. made a new start as SCREEN Holdings Co., Ltd. in October 2014. Over the past 148 years, our commitment to continuously meeting evolving needs has enabled us to grow into a global enterprise employing nearly 10,000 people worldwide.
With its Cell3iMager series SCREEN provides simple, high-throughput, and non-invasive solutions specifically to simplify and accelerate quantitative and qualitative measurement of 3D spheroids and organoids.